Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Glitazones and pancreatic function].

J Girard1

  • 1INSERM U567/CNRS UMR 8104, Institut Cochin, Département d'Endocrinologie-Métabolisme, Faculté de Médecine Cochin-Port Royal, F-75674 Paris Cedex 14, France. girard@cochin.inserm.fr

Annales D'Endocrinologie
|June 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transduction of leptin growth signals in placental cells is independent of JAK-STAT activation.

Placenta·2003
Same author

Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function.

The Journal of clinical endocrinology and metabolism·2002
Same author

[PPARgamma and insulin resistance].

Annales d'endocrinologie·2002
Same author

[Antidiabetic effect of thiazolidinediones].

Journees annuelles de diabetologie de l'Hotel-Dieu·2001
Same author

Therapeutic perspectives for type 2 diabetes mellitus: molecular and clinical insights.

Diabetes & metabolism·2001
Same author

Dissociation between insulin-mediated signaling pathways and biological effects in placental cells: role of protein kinase B and MAPK phosphorylation.

Endocrinology·2001
Same journal

[18F]F-DOPA and [18F]F-FDG PET/CT for staging advanced medullary thyroid cancer.

Annales d'endocrinologie·2026
Same journal

Corrigendum to 'Pink adipose tissue: A paradigm of adipose tissue plasticity' [Ann. Endocrinol. 85 (2004) 248-51].

Annales d'endocrinologie·2026
Same journal

Intraoperative location of parathyroid glands during total thyroidectomy: a systematic review of the literature according to the PRISMA method.

Annales d'endocrinologie·2026
Same journal

Clinical and genetic diagnosis of PHP1A associated with hypogonadism in a young male: A case report.

Annales d'endocrinologie·2026
Same journal

Autoimmune features in acquired generalized lipodystrophy and anti-perilipin 1 antibodies: A case report.

Annales d'endocrinologie·2026
Same journal

The diagnostic challenge of occult glucocorticoid exposure causing Cushing's syndrome.

Annales d'endocrinologie·2026
See all related articles

This study explores how thiazolidinediones, like rosiglitazone, protect pancreatic beta-cells in Zucker Diabetic Fatty rats. These findings offer insights into preserving beta-cell function in type 2 diabetes.

Area of Science:

  • Endocrinology and Metabolism
  • Molecular Biology
  • Pathophysiology of Diabetes

Background:

  • Type 2 diabetes involves insulin resistance and impaired insulin secretion.
  • Progressive beta-cell failure is a key feature, potentially due to glucotoxicity and lipotoxicity.
  • Understanding beta-cell dysfunction is crucial for managing hyperglycemia.

Purpose of the Study:

  • To investigate the protective effects of thiazolidinediones (glitazones) on pancreatic beta-cells.
  • To examine the role of rosiglitazone in preserving beta-cell function in a relevant animal model.
  • To elucidate the mechanisms underlying beta-cell protection in the context of type 2 diabetes.

Main Methods:

  • Utilized the Zucker Diabetic Fatty (ZDF) rat model.

Related Experiment Videos

  • Administered rosiglitazone as both a preventive and curative treatment.
  • Evaluated the impact on pancreatic beta-cell function and secretory capacity.

    • Main Results:

    • Rosiglitazone demonstrated a protective effect on pancreatic beta-cells in ZDF rats.
    • Treatment preserved the secretory function of beta-cells.
    • Evidence suggests a link between glucolipotoxicity and beta-cell apoptosis.

    Conclusions:

    • Thiazolidinediones, exemplified by rosiglitazone, can protect pancreatic beta-cells.
    • These agents preserve beta-cell secretory function, offering therapeutic potential for type 2 diabetes.
    • Further research into glucolipotoxicity mechanisms and therapeutic interventions is warranted.